{site_meta && site_meta.display_name} Logo

NewMediaWire

NewMediaWire distributes press releases on behalf of hundreds of publicly traded companies, as well as private corporations, non-profits and other public sector organizations. Founded and staffed by industry veterans, we offer a full complement of services including specialized delivery to financial sites and posting of photos and multimedia content. In addition, NewMediawire offers international and specialized services such as IR websites and industry specific distribution.

RSS Feed for NewMediaWire

10X Health Appoints Jeff Zwiefel as President & Chief Operating Officer and Expands Executive Leadership Team to Accelerate Global Growth in Precision Health and Human Performance

March 28, 2026SCOTTSDALE, AZ - March 27, 2026 (NEWMEDIAWIRE) - 10X Health, a leader in personalized health optimization and performance-driven wellness solutions, today announced the appointment of Jeff Zwiefel as President and Chief Operating Officer, alongside the expansion of its executive leadership team - marking a significant step forward in the company's mission to become a global leader in precision health, human performance, and longevity. Zwiefel brings more than three decades of executive leadership in the health, fitness, and wellness industry.


Ezalife Gains Early Revenue and Investor Momentum Ahead of StartEngine Campaign Close

March 28, 2026COLUMBUS, OH - March 27, 2026 (NEWMEDIAWIRE) - Ezalife, a medical device company focused on improving outcomes for patients with feeding tubes, is gaining early traction as it approaches the final days of its equity crowdfunding campaign on StartEngine, closing April 6. The company recently reported $8,000 in pre-orders followed by $11,000 in its first 30 days of sales, signaling strong early demand for its flagship product, the Button Huggie®.


Forian Inc. Announces Fourth Quarter and Full Year 2025 Financial Results

March 27, 2026NEWTOWN, PA - March 27, 2026 (NEWMEDIAWIRE) - Forian Inc. (Nasdaq: FORA), a leading provider of data science driven information and analytics solutions to the life science, healthcare and financial services industries, today announced results for the quarter and year ended December 31, 2025.


Lixte Biotech (LIXT) Advances Precision Oncology With LB-100, Strengthens Position Through Liora Technologies Partnership

March 27, 2026LOS ANGELES, CA - March 27, 2026 (NEWMEDIAWIRE) - Lixte Biotech Holdings (NASDAQ: LIXT) is advancing the frontiers of precision oncology, developing therapies that complement existing cancer treatments while integrating cutting-edge data solutions. The company’s lead program, LB-100, is a novel small-molecule compound designed to enhance the efficacy of chemotherapy and radiation, aiming to improve patient outcomes while reducing treatment-related side effects.


B2i Digital Named Marketing Partner for Centri Capital Conference 2026

March 27, 2026B2i Digital to Showcase Emerging Growth Companies Ahead of April 14, 2026 Conference at Nasdaq MarketSite in New York City NEW YORK, NY - March 27, 2026 (NEWMEDIAWIRE) - B2i Digital, Inc. has been named Marketing Partner for the 2026 Centri Capital Conference, taking place on Tuesday, April 14, 2026, at Nasdaq MarketSite in New York City.


Aptevo's Mipletamig Shows 86% Clinical Benefit Rate In Frontline AML As Emerging Data Demonstrate Additive Benefit To Standard Of Care Treatment

March 27, 2026By Meg Flippin, Benzinga DETROIT, MICHIGAN - March 27, 2026 (NEWMEDIAWIRE) - Acute myeloid leukemia (AML) is one of the most difficult blood cancers to treat – especially for older patients or those with other health conditions who cannot tolerate intensive chemotherapy. For many of these patients, treatment options are limited and outcomes remain poor.


Ethema Hires Veteran CFO James M. Poage

March 27, 2026WEST PALM BEACH, FL - March 27, 2026 (NEWMEDIAWIRE) - Ethema Health Corporation (OTCID: GRST) (“Ethema” “GRST” or the “Company”), and its Board of Directors, announces the appointment of James M. Poage as CFO.


CardioDialysisTM, a Next-Generation Technology to Reduce Major Adverse Cardiovascular Events

March 27, 2026SAN DIEGO, CA - March 27, 2026 (NEWMEDIAWIRE) - Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), developer of CardioDialysisTM, a medical device that enables continuous broad-spectrum clearance of inflammatory and pathogenic molecules from the bloodstream, today released the following note authored by CEO and inventor, Jim Joyce.


Eco Science Solutions Integrates IDScan.net's DIVE Into Herbo Pay to Power Identity Verification, Compliance, and Fraud Prevention

March 27, 2026Integration Strengthens Onboarding and Transaction Workflows for Merchants Operating in Regulated, Specialized, and High-Compliance Sectors SAN CLEMENTE, CA - March 27, 2026 (NEWMEDIAWIRE) - Eco Science Solutions, Inc. (OTC: ESSI), a financial technology company focused on compliance-oriented payments infrastructure, today announced the integration of IDScan.


HKTDC's Response to Hong Kong's Export Figures for February

March 27, 2026HONG KONG - March 27, 2026 (NEWMEDIAWIRE) - The Census and Statistics Department today released the latest external merchandise trade statistics. In February 2026, the total value of merchandise exports increased by 24.


Catalyst Crew Technologies Introduces CardioAI, An AI-Driven Platform for Cardiovascular Risk Assessment and Clinical Decision Support

March 27, 2026CARACAS, VENEZUELA - March 26, 2026 (NEWMEDIAWIRE) - Catalyst Crew Technologies Corp. (OTC: CCTC) (the “Company”), a digital health and artificial intelligence technology company developing telehealth infrastructure and healthcare analytics platforms for emerging markets, today announced the ongoing development of CardioAI, an artificial intelligence-enabled module designed to support cardiovascular risk assessment and predictive modeling.


Stefan Bauerreis Becomes New Chief Financial Officer (CFO) of Medios AG

March 26, 2026BERLIN - March 26, 2026 (NEWMEDIAWIRE) - The Supervisory Board of Medios AG has appointed Stefan Bauerreis as a member of the Executive Board and as the Company’s new Chief Financial Officer (CFO), effective April 15, 2026. He succeeds Falk Neukirch, who - as announced on March 6, 2026 – will step down at his own request at the end of his regular term of office on April 30, 2026.


PNE AG Closes the 2025 Financial Year With Successful Operational Performance and Focuses on Core Markets and Profitability

March 26, 2026 Best total operating revenue in the Company’s history EBITDA before special effects at EUR 87. 0 million Transformation and efficiency programme launched Normalised EBITDA of between EUR 110 million and EUR 140 million expected for 2026 CUXHAVEN, GERMANY - March 26, 2026 (NEWMEDIAWIRE) - PNE AG successfully completed the 2025 financial year from an operational perspective and, despite a challenging market environment, confirmed its profitability in its core business.


Martial Arts History Museum Celebrates and Preserves Asian Culture in Los Angeles

March 26, 2026LOS ANGELES, CA - March 26, 2026 (NEWMEDIAWIRE) - The Martial Arts History Museum stands as a cultural cornerstone in Los Angeles, offering a rare and meaningful exploration of Asian history, traditions, and artistic expression. More than a museum of physical discipline, it serves as a bridge between generations and cultures, bringing the depth and beauty of Asian heritage to one of the most diverse cities in the world.


Soligenix (SNGX) Receives EU Orphan Drug Designation For Dusquetide In Behcet Disease

March 26, 2026LOS ANGELES, CA - March 26, 2026 (NEWMEDIAWIRE) - Soligenix (NASDAQ: SNGX) announced the European Commission has granted orphan drug designation to dusquetide (SGX945) for the treatment of Behcet Disease, following a positive recommendation from the European Medicines Agency and supportive Phase 2a data demonstrating biological efficacy and safety. The designation provides up to 10 years of market exclusivity in the European Union and adds to existing FDA orphan and fast track designations, as the company advances its innate defense regulator platform targeting unmet needs in rare autoimmune conditions.


D-Wave Quantum (QBTS) to Premiere "Quantum Matters" Podcast

March 26, 2026LOS ANGELES, CA - March 26, 2026 (NEWMEDIAWIRE) - D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave” or the “Company”), the only dual-platform quantum computing company providing both annealing and gate-model systems, software and services, recently announced that it will launch a new podcast series, “Quantum Matters,” on April 7, 2026.